A Genetic Risk Score Is Associated with Weight Loss Following Roux-en Y Gastric Bypass Surgery

BACKGROUND: Currently, Roux-en Y gastric bypass (RYGB) is the most efficient therapy for severe obesity. Weight loss after surgery is, however, highly variable and genetically influenced. Genome-wide association studies have identified several single nucleotide polymorphisms (SNP) associated with bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandstein, Marcus, Voisin, Sarah, Nilsson, Emil K., Schultes, Bernd, Ernst, Barbara, Thurnheer, Martin, Benedict, Christian, Mwinyi, Jessica, Schiöth, Helgi B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985537/
https://www.ncbi.nlm.nih.gov/pubmed/26832135
http://dx.doi.org/10.1007/s11695-016-2072-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985537/
https://www.ncbi.nlm.nih.gov/pubmed/26832135
http://dx.doi.org/10.1007/s11695-016-2072-9

Ejemplares similares